Haloperidol Tablet
Product Images NDC 55154-3566

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Haloperidol (NDC 55154-3566). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cardinal Health 107, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Bag Label (Eaabdc53 366f 4dc2 B9c7 0d70f1bbb6f9 00)

Bag Label (Eaabdc53 366f 4dc2 B9c7 0d70f1bbb6f9 00)
Haloperidol Tablets, USP 5 mg, is a prescription drug. It is manufactured by Cadila Healthcare Ltd in India and distributed by 2ydus Pharmaceuticals USA Inc, Livonia, MI 48152 USA, and Cardinal Health in Dublin, OH 43017, USA. Each tablet of Haloperidol contains 5 mg of Haloperidol, USP. This unit dose package is not child-resistant and is intended for institutional use only. Hence, it is essential to keep this and ail drugs out of the reach of children. For more details regarding the product insert for prescribing information, precautions, and warnings, you can visit www.majorpharmaceuticals.com. It is recommended to store the tablets at a controlled room temperature of 20° to 25° C (88 to 77° F) in a light-resistant container.*
FDA Label Image

Structured Formula For Haloperidol (C9cf611d 3458 4e48 Af2a A5d9aa4fe990 01)

Structured Formula For Haloperidol (C9cf611d 3458 4e48 Af2a A5d9aa4fe990 01)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.